RxSight, Inc.

RXST - Financial Snapshot

Metrics for RXST

Price $12.31
Shares Outstanding 41.12M
Net Current Assets / Share $6.11
netCurrentAssetsPerShare = (Current Assets - Total Liabilities) / Shares Outstanding
Net Tangible Assets / Share $6.71
netTangibleAssetsPerShare = (Total Assets - Intangibles - Total Liabilities) / Shares Outstanding
Max Earning Power / Share $-2.07
maxEarningPowerPerShare = (EBITDA / EP_MULTIPLIER) / Shares Outstanding
Adjusted Earning Power $-2.27
adjustedEarningPower = (Net Income / EP_MULTIPLIER) / Shares Outstanding
Non-Cash Charges to Market Cap 0.16%
nonCashChargeToMKTCAP = Non-Cash Charges / Market Capitalization
Ave Max Earning Power (5Y) $0.00
Ave Max Earning Power (5Q Annualized) $0.00
Ave Max Earning Power Delta (5Q Ann - 5Y) $0.00
Net Cash / Share $4.8
cashValuePerShare = (Cash + Short Term Investments - Total Liabilities) / Shares Outstanding
Data as of: Price 12-18-25 16:00 ET, Balance Sheet 2025-09-30, Income Statement 2025-09-30, Cash Flow 2025-09-30

Indicators

Dividend indicators Value Date
Pays Dividend No 12-19-2025
Income indicators Value Date
EBITDA Positive No 12-19-2025
Net Income Positive No 12-19-2025
Avg CA Burn (Annual %) 10.59% 12-19-2025
Avg CA Burn (Quarterly %) -0.27% 12-19-2025

Shares Outstanding Changes

Date Shares Outstanding Delta
2025-11-07 41,116,640 +200,677
2025-09-17 40,915,963 -37

RxSight, Inc., a commercial-stage medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adjustable Lens (LAL), an intraocular lens made of photosensitive material that changes shape in response to specific patterns of ultraviolet, which can be adjusted to improve uncorrected visual acuity; and RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.